Probing into the realm of proteins and immunity

Protein Science

Volumn 7, Issue 7, 1998, Pages 1653-1659

  Sela, Michael ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; PROTEIN; RIBONUCLEASE;

ART; ARTICLE; CHEMISTRY; HISTORY; IMMUNOLOGY; ISRAEL; LITERATURE;

ALLERGY AND IMMUNOLOGY; ANTIBODIES; AUTOBIOGRAPHY; HISTORY, 20TH CENTURY; ISRAEL; PORTRAITS; PROTEINS; RIBONUCLEASES;

EID: 0032111406     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560070723     Document Type: Article

References (32)

1. Aboud-Pirak E, Hurwitz E, Pirak ME, Bellot F. Schlessinger J, Sela M. 1988. Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. J Natl Cancer Inst 80:1605-1611.
2. Arnon R. 1996. The development of Cop 1 (Copaxone), an innovative drug for the treatment of multiple sclerosis: Personal reflections. Immunol Lett 50:1-15.
3. Arnon R, Maron E, Sela M, Anfinsen CB. 1971. Antibodies reactive with native lysozyme elicited by a completely synthetic antigen. Proc Natl Acad Sci USA 68:1450-1455.
4. Bornstein MB, Miller A, Slagle S, Weitzmann M, Wassertheil-Smoller S, Spada V, Weiss W, Arnon R, Jacobson I. Teitelbaum D, Sela M. 1987. A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis. N Engl J Med 317:408-414.
5. Fridkis-Hareli M, Teitelbaum D, Gurevich E, Pecht I, Brautbar H, Kwon OJ, Brenner T, Arnon R, Sela M. 1994. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen presenting cells specificity and promiscuity. Proc Natl Acad Sci USA 91:4872-4876.
6. Jacob CO, Sela M, Arnon R. 1983. Antibodies against synthetic peptides of the B subunit of cholera toxin: Cross-reaction and neutralization of the toxin. Proc Natl Acad Sci USA 80:7611-7615.
7. Jagendorf AT, Patchornik A, Sela M. 1963. Use of antibody bound to modified cellulose as an immunospecific adsorbent of antigens. Biochim Biophys Acta 78:516-528.
8. Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP, Myers LW. Panitch HS. Rose JW, Schiffer RB. Vollner T, Weiner LP, Wolinsky JS, and the Copolymer I Multiple Sclerosis Study Group. 1995. Copolymer 1 reduces relapse rate and improves disability in relapsin-remitting multiple sclerosis: Results of a phase III multichain, double-blind, place-controlled trial. Neurology 45:1268-1276.
9. Katchalski-Katzir E. 1993. Poly-α-amino acids as the simplest protein models: Recollections of a retired state president. Protein Sci 2:476-482.
10. Katz-Levy Y, Paas-Rozner M, Kirshner S, Dayan M, Zisman E, Fridkin M, Wirguin I, Sela M, Mozes E. 1997. A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses. Proc Natl Acad Sci USA 94:3200-3205.
11. Klapper LN, Vaisman N, Hurwitz E, Pinkas-Kramarski R, Yarden Y, Sela M. 1997. A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/ HER2 blocks crosstalk with growth factor receptor. Oncogene 14:2099-2109.
12. Levy R. Hurwitz E, Maron R, Arnon R. Sela M. 1975. The specific cytotoxic effects of daunomycin conjugated to anti-tumor antibodies. Cancer Res 35:1182-1191.
13. McDevitt HO, Askonas BE, Humphrey JH, Schechter I, Sela M. 1966. The localization of antigen in relation to specific antibody-producing cells. I. Use of a synthetic polypeptide (T,G)-A-L labelled with iodine-125. Immunology 11:337-351.
14. McDevitt HO, Sela M. 1965. Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polyeptide antigens in two strains of inbred mice. J Exp Med 122:517-531.
15. McDevitt HO, Sela M. 1967. Genetic control of the antibody response. II. Further analysis of the specificity of determinant-specific control, and genetic analysis of the response to (H,G)-A-L in CBA and C57 mice. J Exp Med 126:969-978.
16. Robbins JB, Haimovich J, Sela M. 1967. Purification of antibodies with immunoadsorbents prepared using bromoacetyl cellulose. Immunochemistry 4:11-22.
17. Schlechter B, Conway-Jacobs A, Sela M. 1971. Conformational changes in a synthetic antigen induced by specific antibodies. Eur J Biochem 20:321-324.
18. Sela M, 1966. Immunological studies with synthetic polypeptides. Adv Immunol 5:29-129.
19. Sela M, 1969. Antigenicity: Some molecular aspects. Science 166:1365-1374.
20. Sela M, 1972. Vaccins synthetiques - Un reve ou une realite. In: La Microbiologie Cent Ans Apres Pasteur, Symposium, Paris. Bull Inst Pasteur 2:73-86.
21. Sela M, Arnon R. 1960. Studies on the chemical basis of the antigenicity of proteins. I. Antigenicity of polypeptidyl gelatins. Biochem J 75:91-102.
22. Sela M, Arnon R, Teitelbaum D. 1990. Suppressive activity of Cop I in EAE and its relevance to multiple sclerosis. Bull Inst Pasteur 88:303-314.
23. Sela M, Katchalski E. 1956. Spectrophotometric titration of α-amino acids copolymers containing tyrosine. J Am Chem Soc 78:3986-3989.
24. Sela M, Mozes E, 1966. Dependence of the chemical nature of antibodies on the net electrical charge of antigens. Proc Natl Acad Sci USA 55:445-452.
25. Sela M, Pecht I, 1996. The nature of antigen. Adv Protein Chem 49:287-326.
26. Sela M, Sarid S, 1956. Appearance of serine upon alkaline incubation of iodinated polytyrosine. Nature 178:540-541.
27. Sela M, Schechter B, Schechter I, Borek F, 1967. Antibodies to sequential and conformational determinants. Cold Spring Harbor Symp Quant Biol 32:537-545.
28. Sela M, White FH Jr, Anfinsen CB. 1957. Reductive cleavage of disulfide bridges in ribonuclease. Science 125:691-692.
29. Sela M, White FH Jr, Anfinsen CB. 1959. The reductive cleavage of disulfide bonds and its application to problems of protein structure. Biochim Biophys Acta 31:417-426.
30. Sela M, Zisman E, 1997. Different roles of D-amino acids in immune phenomena. FASEB J 11:449-456.
31. Stancovski I, Hurwitz E, Leitner D, Ullrich A, Yarden Y, Sela M. 1991. Mechanistic aspects of the opposing effects of monoclonal antibodies to the ErbB-2 receptor on tumor growth. Proc Natl Acad Sci USA 88:8691-8695.
32. Tsukada Y, Hurwitz E, Kashi R, Sela M, Hibi N, Hara A, Hirai H. 1982. Chemotherapy by intravenous administration of conjugates of daunomycin with monoclonal and conventional anti-rat α-fetoprotein antibodies. Proc Natl Acad Sci USA 79:7896-7899.